Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £18.13m
KAKU Live PriceLast checked at - London Stock Exchange

Intraday Kakuzi Share Chart

Half-year Report

21 Aug 2024 07:00

RNS Number : 1386B
Kakuzi Ld
21 August 2024
 

KAKUZI PLC

 

 

EXTRACT FROM THE INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD OF SIX MONTHS TO 30 JUNE 2024

The unaudited results for the Kakuzi Group for the period of six months to 30 June 2024 and the comparative figures for the previous year are as follows:

 

Condensed Consolidated Statement of Profit or Loss and other Comprehensive Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2024

 

30 June 2023

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

Sales

1,175,166

873,155

 

Profit before fair value gain in non-current biological assets and income tax

485,583

149,528

  Fair value gain in non-current biological assets

21,509

21,591

 

Profit before income tax

507,092

171,119

Income tax expense

(159,581

)

(53,621

)

Profit for the period

347,511

117,498

  Other Comprehensive Income:

Items that are not reclassified to profit or loss:

Remeasurement of post-employment benefit obligations (net of tax)

-

-

Total comprehensive income

347,511

117,498

 

Shs

 

Shs

 

 

Earnings per share (Shs):

 

 

 

 

 

Basic and diluted earnings per ordinary share

17.73

5.99

 

Condensed Consolidated Statement of Financial Position

 

 

 

 

 

 

 

 

 

Audited

 

 

 

 

 

 

30 June 2024

 

30 June 2023

 

31 December 2023

 

 

 

 

 

 

Shs'000

 

Shs'000

 

Shs'000

 

EQUITY

Share capital

98,000

98,000

98,000

Other reserves

34,929

32,815

34,929

Retained earnings

5,678,264

5,465,134

5,330,753

Proposed dividends

-

-

470,400

Total equity

5,811,193

5,595,949

5,934,082

Non-current liabilities

1,244,674

1,203,079

1,299,213

7,055,867

6,799,028

7,233,295

REPRESENTED BY

Non-current assets

3,986,091

4,097,646

4,055,135

Cash assets excluding cash and bank balances

3,456,440

2,842,579

2,152,846

Cash and bank balances

130,377

239,675

1,408,131

Current liabilities

(517,041

)

(380,872

)

(382,817

)

Net working capital

3,069,776

2,701,382

3,178,160

7,055,867,

6,799,028

7,233,295

 

 

Condensed Consolidated Statement of Cash flows

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2024

 

30 June 2023

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

Cash and cash equivalents at the beginning of the period

1,408,131

1,408,744

 

Net cash used in operating activities

(536,131

)

(597,169

)

Net cash used in investing activities

(107,891

)

(159,841

)

Net cash used in financing activities

(470,400

)

(470,400

)

Effect of exchange rate differences on cash and cash equivalents

(163,332

)

58,341

Decrease in cash and cash equivalents

(1,277,754

)

(1,169,069

)

Cash and cash equivalents at the end of the period

130,377

239,675

 

 

 

Condensed Consolidated Statement of Changes in Equity

 

 

 

 

 

 

Share

capital

 

Other reserves

 

Retained earnings

 

Proposed dividends

 

Total Equity

 

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

 

 

 

 

 

 

 

 

 

 

 

At start of the period

98,000

34,929

5,330,753

470,400

5,934,082

Profit for the period

-

-

347,511

-

347,511

Dividends paid

-

-

-

(470,400

)

(470,400

)

 

At end of period

98,000

34,929

5,678,264

-

5,811,193

 

KEY HIGHLIGHTS

·  Avocado profits were Ksh 951 million, up 42% on the same period last year.

·  Macadamia markets are recovering from last year's slump. A profit of Ksh.32 million has been recorded against a loss of Ksh.329 million last year.

·  The diversification into an expanded range of value addition products, sold through our Kakuzi Farm Market and the Boran Barn has made a positive contribution to sales.

·  Pretax profit for half year is significantly higher than last year at Ksh.507 million.

·  Profits have been negatively impacted by a foreign exchange loss of Ksh.163million.

 

TRADING PERFORMANCE

The half-year trading period for the financial year 2024 has been positively impacted by a buoyant international avocado market, created predominantly by reduced global supply. Demand for macadamia nuts has returned to pre-COVID levels. Although macadamia prices have recovered some ground, they remain below pre-COVID levels. 

 

 

Our commitment to promoting responsibly grown Kenyan superfoods in both traditional and emerging markets is unwavering. Quality, traceability, and sustainability are our key drivers, and we are encouraged to see a growing customer base appreciating our value-added produce range of edible oil, fresh meats, roasted and coated macadamia nuts.

 

The Directors do not recommend the payment of an Interim Dividend.

 

BY ORDER OF THE BOARD

 

NICHOLAS NG'ANG'A

CHAIRMAN

20 AUGUST 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BDGDIISDDGSG
12
Date   Source Headline
25th Mar 20267:00 amRNSAnnual Financial Report
19th Nov 20257:00 amRNSCAUTIONARY ANNOUNCEMENT
20th Aug 20257:00 amRNSHalf-year Report
25th Mar 20257:00 amRNS2024 Final Results Announcement
27th Nov 20246:30 pmRNSProfit Warning Announcement
21st Aug 20247:00 amRNSHalf-year Report
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.